Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-21-067740

SVP of Business Development acquired 4,285 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Flowers Lee SVP of Business Development 2021-12-01 Option exercise +4,285 $0.14 $600 95,952 D
Derivatives
Flowers Lee SVP of Business Development 2021-12-01 Option exercise · Stock Option (Right to Buy) −4,285 12,857 D
Loading xslF345X03/doc4.xml…